BioMarin Pharmaceutical
BMRN
#1409
Rank
A$19.41 B
Marketcap
$101.85
Share price
0.19%
Change (1 day)
-22.60%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): A$0.58 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$2.75 Billion. In 2023 the company made an earning of A$0.28 Billion, an increase over its 2022 earnings that were of A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.58 B103.28%
2023 A$0.28 B26.07%
2022 A$0.22 B-298.51%
2021 -A$0.12 Billion78.04%
2020 -A$64.28 Million-55.36%
2019 -A$0.15 Billion-33.56%
2018 -A$0.22 Billion297.78%
2017 -A$54.48 Million-95.68%
2016 -A$1.27 Billion437.12%
2015 -A$0.24 Billion23.91%
2014 -A$0.19 Billion-29.25%
2013 -A$0.27 Billion49.23%
2012 -A$0.18 Billion171.11%
2011 -A$66.26 Million103.01%
2010 -A$32.64 Million-3903.54%
2009 A$0.85 M-98.31%
2008 A$50.75 M-189.7%
2007 -A$56.59 Million51.02%
2006 -A$37.47 Million-61.58%
2005 -A$97.52 Million-56.59%
2004 -A$0.23 Billion95.13%
2003 -A$0.12 Billion12.09%
2002 -A$0.11 Billion73.19%
2001 -A$59.3 Million18.32%
2000 -A$50.12 Million19.65%
1999 -A$41.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.79 Billion-232.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.32 Billion-152.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$61.81 Million-110.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.24 B 1,792.41%๐Ÿ‡ซ๐Ÿ‡ท France
-A$0.16 Billion-125.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B-76.10%๐Ÿ‡บ๐Ÿ‡ธ USA